Voriconazole Plasma Concentrations in Immunocompromised Pediatric Patients Vary by <i>CYP2C19</i> Diplotypes

J. Kevin Hicks(Moffitt Cancer Center), Mary V. Relling(St. Jude Children's Research Hospital), Jeffrey R. Scott(St. Jude Children's Research Hospital), Cyrine E. Haidar(St. Jude Children's Research Hospital), Deepa Bhojwani(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Wenjian Yang(St. Jude Children's Research Hospital), John C. Panetta(St. Jude Children's Research Hospital), Alejandro R. Molinelli(St. Jude Children's Research Hospital), Kristine R. Crews(St. Jude Children's Research Hospital), Ulrich Broeckel(Medical College of Wisconsin), Patricia M. Flynn(St. Jude Children's Research Hospital), Deqing Pei(St. Jude Children's Research Hospital), Calvin C. Daniels(St. Jude Children's Research Hospital)
Pharmacogenomics
June 1, 2014
Cited by 68


Related Papers